Natalizumab, anti alfa-4 integrin humanisert monoklonalt antistoff - forlenget SPC
- 专利权人:
- Biogen MA Inc.
- 发明人:
- 申请号：
- NO2017040
- 公开号：
- NO2017040I1
- 申请日:
- 2017.08.01
- 申请国别(地区):
- NO
- 年份:
- 2017
- 代理人:
- 摘要：
- The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for the treatment of multiple sclerosis.
- 来源网站：
- 中国工程科技知识中心
